|
Market Closed -
Hong Kong S.E.
11:08:09 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4900 HKD | +8.89% |
|
-3.92% | -2.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +8.89% | -3.92% | +10.11% | +16.67% | -2.00% | -19.67% | +3.16% | -46.15% | - | 237M | |
| +4.16% | +3.04% | +8.38% | +33.66% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.41B | |
| -1.47% | -1.85% | -7.88% | +0.53% | +15.74% | +24.04% | +77.64% | +223.56% | +5,383.15% | 59.26B | |
| +1.39% | -0.32% | -2.74% | +0.50% | +5.50% | +4.61% | +34.93% | -17.79% | +204.24% | 47.14B | |
| -3.02% | -5.20% | +0.92% | +28.31% | +15.66% | +27.94% | +32.51% | +7.94% | +221.64% | 42.91B | |
| +0.31% | +3.02% | -1.90% | +9.80% | +158.49% | +348.95% | +643.82% | +607.04% | - | 44.13B | |
| -1.96% | -0.33% | +0.03% | +23.40% | +18.09% | +7.04% | +99.46% | +0.58% | +1,064.46% | 40.79B | |
| +3.32% | +3.49% | -2.34% | +5.21% | +6.51% | +10.10% | +51.23% | -9.95% | +145.56% | 30.77B | |
| -2.68% | +2.92% | +10.78% | +52.12% | +73.51% | +29.63% | +22.72% | -52.81% | - | 29.31B | |
| -4.86% | -10.66% | -10.63% | +1.49% | -37.61% | -26.27% | +330.06% | +296.60% | +647.87% | 23.71B | |
| -1.48% | -2.43% | -5.00% | +3.12% | +1.73% | -5.24% | -10.85% | -61.99% | - | 24.33B | |
| -0.63% | +1.32% | +6.07% | +23.11% | +13.81% | +13.93% | -5.61% | -15.28% | +102.01% | 20.81B | |
| -4.18% | -3.63% | +2.55% | +10.03% | +6.49% | +9.96% | +147.01% | +205.72% | +1,902.95% | 16.69B | |
| -3.70% | +1.30% | -10.69% | -4.57% | +176.14% | +132.17% | +328.65% | +1,700.34% | +638.60% | 15.17B | |
| -0.23% | -1.47% | -12.66% | -15.12% | - | - | - | - | - | 14.93B | |
| -3.04% | +1.11% | -4.22% | +0.98% | +20.40% | -16.05% | +500.76% | - | - | 14.84B | |
| +0.75% | -2.90% | +3.22% | +8.65% | +20.38% | +19.54% | +43.52% | -28.29% | +82.51% | 14.57B | |
| -6.59% | -6.98% | +22.85% | +24.19% | +29.55% | -13.06% | - | - | - | 13.8B | |
| -0.80% | -0.02% | +1.85% | +7.38% | +32.19% | +40.63% | +165.17% | +168.99% | +353.01% | 14.36B | |
| -2.77% | -2.58% | +1.59% | +25.20% | +43.79% | +68.25% | +46.36% | -31.16% | +244.17% | 13.69B | |
| Average | -0.52% | -0.18% | +0.51% | +12.73% | +35.95% | +37.15% | +144.71% | +173.93% | +915.85% | 27.79B | |
| Weighted average by Cap. | -0.43% | -0.73% | +0.04% | +14.83% | +41.66% | +48.94% | +142.88% | +145.29% | +1,337.49% |
- Stock Market
- Stocks
- 2181 Stock
- Sector Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
